Vanguard Group Inc Corcept Therapeutics Inc Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 9,537,071 shares of CORT stock, worth $720 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,537,071
Previous 9,680,592 1.48%
Holding current value
$720 Million
Previous $711 Million 11.55%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$67.17 - $83.9 $9.64 Million - $12 Million
-143,521 Reduced 1.48%
9,537,071 $793 Million
Q2 2025

Aug 11, 2025
SELL
$62.24 - $91.93 $18.8 Million - $27.7 Million
-301,376 Reduced 3.02%
9,680,592 $711 Million
Q1 2025

May 09, 2025
SELL
$49.85 - $114.22 $6.66 Million - $15.3 Million
-133,656 Reduced 1.32%
9,981,968 $1.14 Billion
Q4 2024

Feb 11, 2025
BUY
$44.66 - $60.85 $4.88 Million - $6.65 Million
109,294 Added 1.09%
10,115,624 $510 Million
Q3 2024

Nov 13, 2024
BUY
$29.51 - $46.26 $13.4 Million - $20.9 Million
452,624 Added 4.74%
10,006,330 $463 Million
Q2 2024

Aug 13, 2024
SELL
$22.21 - $34.48 $268,207 - $416,380
-12,076 Reduced 0.13%
9,553,706 $310 Million
Q1 2024

May 10, 2024
BUY
$21.1 - $27.46 $596,075 - $775,745
28,250 Added 0.3%
9,565,782 $241 Million
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $5.95 Million - $7.89 Million
239,887 Added 2.58%
9,537,532 $310 Million
Q3 2023

Nov 14, 2023
SELL
$21.97 - $33.8 $298,352 - $459,003
-13,580 Reduced 0.15%
9,297,645 $253 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $24.1 Million - $28.3 Million
-1,123,519 Reduced 10.77%
9,311,225 $207 Million
Q1 2023

May 15, 2023
BUY
$19.2 - $24.47 $1.72 Million - $2.2 Million
89,714 Added 0.87%
10,434,744 $226 Million
Q4 2022

Feb 10, 2023
BUY
$19.95 - $29.96 $258,412 - $388,071
12,953 Added 0.13%
10,345,030 $210 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $11.3 Million - $13.3 Million
458,414 Added 4.64%
10,332,077 $265 Million
Q2 2022

Aug 12, 2022
SELL
$17.33 - $25.3 $9.79 Million - $14.3 Million
-565,089 Reduced 5.41%
9,873,663 $235 Million
Q1 2022

May 13, 2022
SELL
$16.53 - $25.21 $5.93 Million - $9.04 Million
-358,725 Reduced 3.32%
10,438,752 $235 Million
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $18.3 Million - $25 Million
-1,073,041 Reduced 9.04%
10,797,477 $214 Million
Q3 2021

Nov 12, 2021
SELL
$19.68 - $22.53 $2.1 Million - $2.41 Million
-106,866 Reduced 0.89%
11,870,518 $234 Million
Q2 2021

Aug 13, 2021
BUY
$19.97 - $24.43 $239 Million - $293 Million
11,977,384 New
11,977,384 $264 Million

Others Institutions Holding CORT

# of Institutions
480
Shares Held
80.5M
Call Options Held
599K
Put Options Held
710K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email